BERKLEY CARE (CHESHAM) LIMITED

Company Registration Number:
10113365 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2022

Period of accounts

Start date: 01 January 2022

End date: 31 December 2022

BERKLEY CARE (CHESHAM) LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2022

Balance sheet
Notes

BERKLEY CARE (CHESHAM) LIMITED

Balance sheet

As at 31 December 2022


Notes

2022

9 months to 31 December 2021


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 8,804,071 9,326,251
Investments: 4 0 1
Total fixed assets: 8,804,071 9,326,252
Current assets
Stocks: 0 0
Debtors: 5 2,014,771 1,281,976
Cash at bank and in hand: 5,175,382 7,643
Investments:   0 0
Total current assets: 7,190,153 1,289,619
Creditors: amounts falling due within one year: 6 (332,781) (10,969,759)
Net current assets (liabilities): 6,857,372 (9,680,140)
Total assets less current liabilities: 15,661,443 (353,888)
Creditors: amounts falling due after more than one year: 7 (11,082,496) 0
Provision for liabilities: 0 (5,587)
Total net assets (liabilities): 4,578,947 (359,475)
Capital and reserves
Called up share capital: 100 100
Share premium account: 0 0
Revaluation reserve: 00
Other reserves: 0 0
Profit and loss account: 4,578,847 (359,575)
Shareholders funds: 4,578,947 (359,475)

The notes form part of these financial statements

BERKLEY CARE (CHESHAM) LIMITED

Balance sheet statements

For the year ending 31 December 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 30 August 2024
and signed on behalf of the board by:

Name: Peter Stuart Cameron
Status: Director

The notes form part of these financial statements

BERKLEY CARE (CHESHAM) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

BERKLEY CARE (CHESHAM) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

2. Employees

2022 9 months to 31 December 2021
Average number of employees during the period 0 0

BERKLEY CARE (CHESHAM) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

3. Tangible Assets

Total
Cost £
At 01 January 2022 10,303,416
Additions 0
Disposals 0
Revaluations 0
Transfers 0
At 31 December 2022 10,303,416
Depreciation
At 01 January 2022 977,165
Charge for year 522,180
On disposals 0
Other adjustments 0
At 31 December 2022 1,499,345
Net book value
At 31 December 2022 8,804,071
At 31 December 2021 9,326,251

BERKLEY CARE (CHESHAM) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

4. Fixed investments

Interests in subsidiaries. associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting data and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.A subsidiary is an entity controlled by the Company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

BERKLEY CARE (CHESHAM) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

5. Debtors

2022 9 months to 31 December 2021
££
Debtors due after more than one year: 0 1,281,976

BERKLEY CARE (CHESHAM) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

6. Creditors: amounts falling due within one year note

Amounts owed to group undertakings 312,980 10,959,859 Accruals and deferred income 19,801 9,900

BERKLEY CARE (CHESHAM) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

7. Creditors: amounts falling due after more than one year note

Amounts owed to group undertakings 11,082,496 -

BERKLEY CARE (CHESHAM) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

8. Related party transactions

As a wholly owned subsidiary undertaking of Clariane SE, the Company has taken advantage of the exemption in FRS 102 Section 33.1A and has not disclosed transactions with entities which form part of the group and they are owned 100% by the parent company.

BERKLEY CARE (CHESHAM) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

9. Post balance sheet events

On 10 April 2024, Clariane SE sold its assets in the United Kingdom to Elevation Healthcare Property, a UK investment fund specialising in healthcare real estate, managed by Elevation Advisors